T

Tiziana Life Sciences Ltd
D

TLSA

0.95800
USD
-0.00
(-0.21%)
Market Closed
Volume
1,815
EPS
-0
Div Yield
-
P/E
-7
Market Cap
99,462,189
OverviewSignalsIdeasNews
Related Instruments
    AAPL
    AAPL
    -3.130
    (-1.37%)
    234.960 USD
    AMZN
    AMZN
    -8.930
    (-4.22%)
    205.740 USD
    F
    F
    -0.060
    (-0.54%)
    11.015 USD
    GM
    GM
    -0.620
    (-1.08%)
    57.010 USD
    G
    GOEV
    -0.03200
    (-5.97%)
    0.50400 USD
    MSFT
    MSFT
    -11.75
    (-2.75%)
    422.86 USD
    N
    NIO
    0.06500
    (1.47%)
    4.49500 USD
    N
    NKLA
    -0.07500
    (-3.12%)
    2.33000 USD
    R
    RIDE
    -0.02030
    (-2.74%)
    0.72000 USD
    More
News

Title: Tiziana Life Sciences Ltd

Sector: Healthcare
Industry: Biotechnology
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.